Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price shot up 47.4% on Friday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares were traded during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company’s 50 day moving average is C$0.07 and its 200 day moving average is C$0.06. The firm has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- What is a buyback in stocks? A comprehensive guide for investors
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
